Showing 20 of 102 recruiting trials for “perihilar-cholangiocarcinoma”
Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)
Enrolling by InvitationNCT06474091 ↗
Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
RecruitingNCT06342414 ↗
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC
RecruitingNCT06261047 ↗
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
👨⚕️ jibo yue, dorctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06277531 ↗
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)
RecruitingNCT06369480 ↗
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
👨⚕️ Hans-Christian Pommergaard, M.D./Ph.D., Rigshospitalet, Denmark📍 1 site📅 Started Feb 2024View details ↗
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
👨⚕️ Feng Cheng, MD, The First Affiliated Hospital with Nanjing Medical University📍 3 sites📅 Started Jan 2024View details ↗
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
👨⚕️ Enrico Gringeri, Prof., Azienda Ospedale Università di Padova📍 1 site📅 Started Jan 2024View details ↗
LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)
👨⚕️ Enrico Gringeri, Prof., Azienda Ospedale Università di Padova📍 1 site📅 Started Jan 2024View details ↗
National Liver Cancer Screening Trial
👨⚕️ Amit Singal, MD, MS, University of Texas Southwestern Medical Center📍 18 sites📅 Started Dec 2023View details ↗
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
RecruitingNCT06140134 ↗
Liver Transplantation in Intrahepatic Cholangiocarcinoma
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Nov 2023View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →